We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
-4.94%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$8.17B
AUM Growth
-$1.72B
(-17%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-14.57%
Top 10 Holdings %
Top 10 Hldgs %
43.28%
Holding
776
New
247
Increased
72
Reduced
119
Closed
260
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$199M |
| 2 |
Warner Bros
WBD
|
+$187M |
| 3 |
Vistra
VST
|
+$171M |
| 4 |
Micron Technology
MU
|
+$162M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$413M |
| 2 |
VMW
VMware, Inc
VMW
|
+$297M |
| 3 |
eBay
EBAY
|
+$211M |
| 4 |
PG&E
PCG
|
+$204M |
| 5 |
Willis Towers Watson
WTW
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.91% |
| 2 | Communication Services | 8.9% |
| 3 | Technology | 7.35% |
| 4 | Consumer Discretionary | 5.83% |
| 5 | Materials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CALL
Citigroup
C
$228B
| $5.84M | 0.07% |
109,300
+9,900
| +10% | +$612K |
|
152
GH Research
GHRS
$2B
| $5.76M | 0.07% |
314,930
-19,662
| -6% | -$347K |
|
153
Arcus Biosciences
RCUS
$3.66B
| $5.72M | 0.07% |
+181,244
| New | +$6.07M |
|
154
Praxis Precision Medicines
PRAX
$10.3B
| $5.57M | 0.07% |
36,359
-480
| -1% | -$98.6K |
|
|
PPL
155
CALL
PPL Corp
PPL
$26.5B
| $5.43M | 0.07% |
+190,000
| New | +$5.36M |
|
156
TJX Companies
TJX
$172B
| $5.42M | 0.07% |
+89,453
| New | +$5.99M |
|
157
PUT
CVS Health
CVS
$120B
| $5.31M | 0.07% |
+52,500
| New | +$5.52M |
|
158
lululemon athletica
LULU
$14.3B
| $5.28M | 0.06% |
14,467
+8,000
| +124% | +$2.6M |
|
|
ICVX
159
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $5.23M | 0.06% |
742,354
-7,646
| -1% | -$120K |
|
|
AMRS
160
DELISTED
Amyris Inc.
AMRS
| $5.21M | 0.06% |
1,195,400
-43,800
| -4% | -$197K |
|
161
Vor Biopharma
VOR
$1.28B
| $5.18M | 0.06% |
42,865
| – | – |
|
162
AnaptysBio
ANAB
$1.71B
| $5.13M | 0.06% |
207,500
+32,500
| +19% | +$984K |
|
163
PUT
Performance Food Group
PFGC
$17.9B
| $5.09M | 0.06% |
+100,000
| New | +$4.9M |
|
164
PUT
IBM
IBM
$225B
| $5.06M | 0.06% |
38,900
| – | – |
|
165
Pyxis Oncology
PYXS
$179M
| $4.93M | 0.06% |
1,219,832
+57,500
| +5% | +$420K |
|
|
VMW
166
DELISTED
VMware, Inc
VMW
| $4.52M | 0.06% |
39,655
-2,451,542
| -98% | -$297M |
|
167
Workday
WDAY
$44.8B
| $4.36M | 0.05% |
+18,204
| New | +$4.34M |
|
|
DCPH
168
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.26M | 0.05% |
+459,290
| New | +$3.91M |
|
169
Li Auto
LI
$12.4B
| $4.06M | 0.05% |
157,394
| – | – |
|
170
CALL
Target
TGT
$69.2B
| $3.97M | 0.05% |
18,700
-33,900
| -64% | -$7.33M |
|
|
MBAC.U
171
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
| $3.93M | 0.05% |
400,000
| – | – |
|
172
4D Molecular Therapeutics
FDMT
$600M
| $3.71M | 0.05% |
245,123
| – | – |
|
173
Howmet Aerospace
HWM
$112B
| $3.65M | 0.04% |
101,606
-70,202
| -41% | -$2.4M |
|
174
Spyre Therapeutics
SYRE
$9.06B
| $3.62M | 0.04% |
63,026
+5,000
| +9% | +$420K |
|
175
Fortinet
FTNT
$119B
| $3.43M | 0.04% |
50,160
+19,500
| +64% | +$1.21M |
|
Similar funds
AFM
GCP
LCM
MAP
MA
NSAM
ABI
OCM
Laurion Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Laurion Capital Management held 776 positions worth $8.17B, down 17% from $9.89B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Laurion Capital Management withdrew a net $1.19B in Q1 2022, closing 260 positions and reducing 119 holdings. Its most notable exit was Marathon Petroleum, an estimated $413M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Laurion Capital Management opened a new position in Qualcomm worth $182M.
- Laurion Capital Management's largest Q1 2022 buy was Qualcomm: 1,189,203 shares worth $182M.
- Laurion Capital Management added most to Warner Bros in Q1 2022, an estimated $187M increase.
- Laurion Capital Management's biggest Q1 2022 reduction was VMware, Inc, cutting an estimated $297M.
- Laurion Capital Management fully exited Marathon Petroleum in Q1 2022, selling an estimated $413M.
- Laurion Capital Management's ten largest holdings make up 43% of its $8.17B portfolio in Q1 2022.
- Laurion Capital Management opened 247 new positions and closed 260 in Q1 2022.
- Laurion Capital Management's portfolio value fell 17% quarter-over-quarter to $8.17B.
Based on Laurion Capital Management's 13F filing for Q1 2022, filed 16 May 2022.